Showing 1 - 6 results of 6 for search 'Anja Tiede', query time: 0.01s Refine Results
  1. 1
    TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure? Correspondence to editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”

    TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure? Correspondence to editorial on “Insertion of a transjugular intrahepatic portosystemic shunt... by Anja Tiede, Benjamin Maasoumy

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis.

    Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis. by Laura Buttler, Anja Tiede, Marie Griemsmann, Hannah Rieland, Jim B Mauz, Heiner Wedemeyer, Markus Cornberg, Tammo L Tergast, Katharina L Hupa-Breier, Benjamin Maasoumy

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis

    Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis by Laura Buttler, Anja Tiede, Marie Griemsmann, Hannah Rieland, Jim B. Mauz, Heiner Wedemeyer, Markus Cornberg, Tammo L. Tergast, Katharina L. Hupa-Breier, Benjamin Maasoumy

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis

    Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis by Anja Tiede, Lena Stockhoff, Zhaoli Liu, Hannah Rieland, Jim B. Mauz, Valerie Ohlendorf, Birgit Bremer, Jennifer Witt, Anke Kraft, Markus Cornberg, Jan B. Hinrichs, Bernhard C. Meyer, Heiner Wedemeyer, Cheng-Jian Xu, Christine S. Falk, Benjamin Maasoumy

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation

    Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation by Laura Buttler, David A. Velázquez-Ramírez, Anja Tiede, Anna M. Conradi, Sabrina Woltemate, Robert Geffers, Birgit Bremer, Vera Spielmann, Julia Kahlhöfer, Anke R.M Kraft, Dirk Schlüter, Heiner Wedemeyer, Markus Cornberg, Christine Falk, Marius Vital, Benjamin Maasoumy

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosis

    Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosis by Jim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, Sarah Lisa Schütte, Paul Hemetsberger, Theresa Müllner-Bucsics, Mathias Jachs, Anja Tiede, Hannah Rieland, Michael Schwarz, Nina Dominik, Georg Kramer, Bernhard Meyer, Lukas Reider, Michael Trauner, Heiner Wedemeyer, Mattias Mandorfer, Benjamin Maasoumy, Thomas Reiberger, Tammo Lambert Tergast

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: